LNTH — Lantheus Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual income statement for Lantheus Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	347	339	425	935	1,296
Cost of Revenue
Gross Profit	175	148	188	582	832
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	299	344	485	899	932
Operating Profit	48.5	-4.2	-59.9	35.6	365
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28.6	-11.5	-75	26.7	411
Provision for Income Taxes
Net Income After Taxes	31.7	-13.5	-71.3	28.1	327
Net Income Before Extraordinary Items
Net Income	31.7	-13.5	-71.3	28.1	327
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	31.7	-13.5	-71.3	28.1	327
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.841	0.042	-1.21	0.403	5.73